Cancer Therapies Market - Global Outlook and Forecast 2021-2027

Code: RW00014595773
Market Monitor Global
Nov-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Cancer Therapies in Global, including the following market information:
Global Cancer Therapies Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Cancer Therapies market was valued at 46540 million in 2020 and is projected to reach US$ 55050 million by 2027, at a CAGR of 4.3% during the forecast period.
Publisher has surveyed the Cancer Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Therapies Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Cancer Therapies Market Segment Percentages, By Type, 2020 (%)
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches

China Cancer Therapies Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Cancer Therapies Market Segment Percentages, By Application, 2020 (%)
Hospital Use
Clinic Use
Household
Other

Global Cancer Therapies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Cancer Therapies Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Cancer Therapies Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Cancer Therapies Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cancer Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Therapies Overall Market Size
2.1 Global Cancer Therapies Market Size: 2021 VS 2027
2.2 Global Cancer Therapies Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Therapies Players in Global Market
3.2 Top Global Cancer Therapies Companies Ranked by Revenue
3.3 Global Cancer Therapies Revenue by Companies
3.4 Top 3 and Top 5 Cancer Therapies Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Therapies Players in Global Market
3.6.1 List of Global Tier 1 Cancer Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Therapies Market Size Markets, 2021 & 2027
4.1.2 Immunological and Vaccine Approaches
4.1.3 Antiproliferative Approaches
4.1.4 Photodynamic Therapy
4.1.5 Gene Therapy Approaches
4.1.6 Cell Cycle and Apoptosis Approaches
4.2 By Type - Global Cancer Therapies Revenue & Forecasts
4.2.1 By Type - Global Cancer Therapies Revenue, 2016-2021
4.2.2 By Type - Global Cancer Therapies Revenue, 2022-2027
4.2.3 By Type - Global Cancer Therapies Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Therapies Market Size, 2021 & 2027
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application - Global Cancer Therapies Revenue & Forecasts
5.2.1 By Application - Global Cancer Therapies Revenue, 2016-2021
5.2.2 By Application - Global Cancer Therapies Revenue, 2022-2027
5.2.3 By Application - Global Cancer Therapies Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cancer Therapies Market Size, 2021 & 2027
6.2 By Region - Global Cancer Therapies Revenue & Forecasts
6.2.1 By Region - Global Cancer Therapies Revenue, 2016-2021
6.2.2 By Region - Global Cancer Therapies Revenue, 2022-2027
6.2.3 By Region - Global Cancer Therapies Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cancer Therapies Revenue, 2016-2027
6.3.2 US Cancer Therapies Market Size, 2016-2027
6.3.3 Canada Cancer Therapies Market Size, 2016-2027
6.3.4 Mexico Cancer Therapies Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cancer Therapies Revenue, 2016-2027
6.4.2 Germany Cancer Therapies Market Size, 2016-2027
6.4.3 France Cancer Therapies Market Size, 2016-2027
6.4.4 U.K. Cancer Therapies Market Size, 2016-2027
6.4.5 Italy Cancer Therapies Market Size, 2016-2027
6.4.6 Russia Cancer Therapies Market Size, 2016-2027
6.4.7 Nordic Countries Cancer Therapies Market Size, 2016-2027
6.4.8 Benelux Cancer Therapies Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cancer Therapies Revenue, 2016-2027
6.5.2 China Cancer Therapies Market Size, 2016-2027
6.5.3 Japan Cancer Therapies Market Size, 2016-2027
6.5.4 South Korea Cancer Therapies Market Size, 2016-2027
6.5.5 Southeast Asia Cancer Therapies Market Size, 2016-2027
6.5.6 India Cancer Therapies Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cancer Therapies Revenue, 2016-2027
6.6.2 Brazil Cancer Therapies Market Size, 2016-2027
6.6.3 Argentina Cancer Therapies Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Therapies Revenue, 2016-2027
6.7.2 Turkey Cancer Therapies Market Size, 2016-2027
6.7.3 Israel Cancer Therapies Market Size, 2016-2027
6.7.4 Saudi Arabia Cancer Therapies Market Size, 2016-2027
6.7.5 UAE Cancer Therapies Market Size, 2016-2027
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Therapies Major Product Offerings
7.1.4 Amgen Cancer Therapies Revenue in Global (2016-2021)
7.1.5 Amgen Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Cancer Therapies Major Product Offerings
7.2.4 AstraZeneca Cancer Therapies Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Cancer Therapies Major Product Offerings
7.3.4 Bristol-Myers Squibb Cancer Therapies Revenue in Global (2016-2021)
7.3.5 Bristol-Myers Squibb Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Cancer Therapies Major Product Offerings
7.4.4 Bayer AG Cancer Therapies Revenue in Global (2016-2021)
7.4.5 Bayer AG Key News
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Cancer Therapies Revenue in Global (2016-2021)
7.5.5 F. Hoffmann-La Roche Ltd Key News
7.6 GlaxoSmithKline PLC
7.6.1 GlaxoSmithKline PLC Corporate Summary
7.6.2 GlaxoSmithKline PLC Business Overview
7.6.3 GlaxoSmithKline PLC Cancer Therapies Major Product Offerings
7.6.4 GlaxoSmithKline PLC Cancer Therapies Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline PLC Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Cancer Therapies Major Product Offerings
7.4.4 Johnson & Johnson Cancer Therapies Revenue in Global (2016-2021)
7.7.5 Johnson & Johnson Key News
7.8 Merck & Co. Inc.
7.8.1 Merck & Co. Inc. Corporate Summary
7.8.2 Merck & Co. Inc. Business Overview
7.8.3 Merck & Co. Inc. Cancer Therapies Major Product Offerings
7.8.4 Merck & Co. Inc. Cancer Therapies Revenue in Global (2016-2021)
7.8.5 Merck & Co. Inc. Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Cancer Therapies Major Product Offerings
7.9.4 Novartis AG Cancer Therapies Revenue in Global (2016-2021)
7.9.5 Novartis AG Key News
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Corporate Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Cancer Therapies Major Product Offerings
7.10.4 Pfizer Inc. Cancer Therapies Revenue in Global (2016-2021)
7.10.5 Pfizer Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Cancer Therapies Market Opportunities & Trends in Global Market
Table 2. Cancer Therapies Market Drivers in Global Market
Table 3. Cancer Therapies Market Restraints in Global Market
Table 4. Key Players of Cancer Therapies in Global Market
Table 5. Top Cancer Therapies Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer Therapies Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer Therapies Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer Therapies Product Type
Table 9. List of Global Tier 1 Cancer Therapies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Therapies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Cancer Therapies Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancer Therapies Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancer Therapies Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Cancer Therapies Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancer Therapies Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancer Therapies Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Cancer Therapies Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancer Therapies Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancer Therapies Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancer Therapies Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancer Therapies Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancer Therapies Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancer Therapies Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancer Therapies Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancer Therapies Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancer Therapies Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancer Therapies Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancer Therapies Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancer Therapies Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Cancer Therapies Product Offerings
Table 32. Amgen Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Cancer Therapies Product Offerings
Table 35. AstraZeneca Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Cancer Therapies Product Offerings
Table 38. Bristol-Myers Squibb Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 39. Bayer AG Corporate Summary
Table 40. Bayer AG Cancer Therapies Product Offerings
Table 41. Bayer AG Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 42. F. Hoffmann-La Roche Ltd Corporate Summary
Table 43. F. Hoffmann-La Roche Ltd Cancer Therapies Product Offerings
Table 44. F. Hoffmann-La Roche Ltd Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 45. GlaxoSmithKline PLC Corporate Summary
Table 46. GlaxoSmithKline PLC Cancer Therapies Product Offerings
Table 47. GlaxoSmithKline PLC Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Cancer Therapies Product Offerings
Table 50. Johnson & Johnson Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 51. Merck & Co. Inc. Corporate Summary
Table 52. Merck & Co. Inc. Cancer Therapies Product Offerings
Table 53. Merck & Co. Inc. Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 54. Novartis AG Corporate Summary
Table 55. Novartis AG Cancer Therapies Product Offerings
Table 56. Novartis AG Cancer Therapies Revenue (US$, Mn), (2016-2021)
Table 57. Pfizer Inc. Corporate Summary
Table 58. Pfizer Inc. Cancer Therapies Product Offerings
Table 59. Pfizer Inc. Cancer Therapies Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Cancer Therapies Segment by Type
Figure 2. Cancer Therapies Segment by Application
Figure 3. Global Cancer Therapies Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Therapies Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancer Therapies Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Therapies Revenue in 2020
Figure 8. By Type - Global Cancer Therapies Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancer Therapies Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancer Therapies Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancer Therapies Revenue Market Share, 2016-2027
Figure 12. US Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancer Therapies Revenue Market Share, 2016-2027
Figure 16. Germany Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancer Therapies Revenue Market Share, 2016-2027
Figure 24. China Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancer Therapies Revenue Market Share, 2016-2027
Figure 30. Brazil Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancer Therapies Revenue Market Share, 2016-2027
Figure 33. Turkey Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancer Therapies Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bristol-Myers Squibb Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer AG Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. F. Hoffmann-La Roche Ltd Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. GlaxoSmithKline PLC Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Johnson & Johnson Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Merck & Co. Inc. Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Novartis AG Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Pfizer Inc. Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE